Clinical Trial Update: Optimizing CAB-LA as PrEP for Women Who Inject Drugs

View source ↗

Summary

Clinical trial update reporting the completion of a study optimizing cabotegravir long-acting as pre-exposure prophylaxis for women who inject drugs.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• APRETUDE (CABOTEGRAVIR)

Snippet

Sponsor: Alexis Roth | Conditions: HIV Infections, Opioid Use | Status: COMPLETED